Tecan And Invitrogen Corporation (IVGN) Announce Agreement To Jointly Develop And Promote Applications Of Invitrogen Research Kits On Tecan Instruments
10/19/2005 5:11:24 PM
Tecan, a leading player in the health care supply industry, and Invitrogen, a provider of essential life science technologies for disease research and drug discovery, today announced an agreement to promote the use of Invitrogen’s research kits on Tecan’s instruments for a wide variety of key biological science and drug discovery applications. Under the non-exclusive open collaboration agreement, Tecan and Invitrogen will collaborate in the development of applications that combine the use of Invitrogen’s products with Tecan’s Freedom EVO® series of automated platforms, multimode detection devices and microarray systems for a range of life science applications, including nucleic acid sample preparation, microarray applications and cell-based assays. Invitrogen and Tecan will work together to develop solutions for each application. Both companies will promote the solutions arising from the collaboration. Financial details were not disclosed.
comments powered by